차세대 RNA 시퀀싱 시장 : 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global next-generation RNA sequencing market size is expected to reach USD 22.47 Billion in 2034 from USD 5.28 Billion in 2025, growing at a CAGR of 17.46% during 2026-2034.This market is expanding as next-generation RNA sequencing becomes increasingly important for transcriptome analysis, gene-expression profiling, and advanced biological research. RNA sequencing can help researchers study transcripts, alternative splicing, gene fusions, and other molecular characteristics, supporting applications across genomics, drug discovery, and precision medicine. Recent market estimates project strong growth in NGS-based RNA sequencing, supported by increasing research activity and the broader use of sequencing technologies in life sciences.

Demand is being supported by improvements in sequencing platforms, library-preparation technologies, bioinformatics, and computational analysis. Pharmaceutical and biotechnology companies are using RNA-sequencing approaches to investigate disease mechanisms, identify biomarkers, and support therapeutic development. Academic and clinical research is also contributing to adoption as researchers require increasingly detailed molecular information. The integration of sequencing with artificial intelligence and advanced analytics can further improve the interpretation of complex transcriptomic datasets and support more efficient research workflows.

Future prospects are linked to declining sequencing costs, improvements in accuracy and throughput, and the expanding application of transcriptomic information. Researchers are expected to increasingly combine RNA sequencing with other genomic and multi-omics approaches to obtain broader biological insights. Advances in single-cell and spatial transcriptomics can create additional opportunities for sequencing providers and analytical platforms. As precision medicine and molecular research continue developing, next-generation RNA sequencing is expected to remain an important technology for understanding gene activity and biological variation.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Product & Service

• Consumables (Extraction & Purification Kits, Library Preparation Kits, Sequencing Reagents & Flow Cells, Others)
• Instruments
• Service (RNA-Sequencing, Bioinformatics & Data Analysis)

By Workflow

• Pre-Sequencing
• Sequencing
• Data Analysis

By Application

• Drug Discovery & Development (Oncology, Infectious Diseases, Others)
• Clinical Diagnostics
• Others

By End Use

• Academic & Research Institutes
• Pharmaceutical & Biotechnology Companies
• Hospitals & Clinics
• Others

COMPANIES PROFILED

• Illumina Inc., Thermo Fisher Scientific Inc., Merck KGaA, QIAGEN N.V., Pacific Biosciences of California Inc., Oxford Nanopore Technologies Ltd., Agilent Technologies Inc., BGI Group, Roche Holding AG, Revvity Inc., Eurofins Scientific, Bio-Rad Laboratories Inc., Takara Bio Inc., Hamilton Company, Macrogen

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL NEXT GENERATION RNA SEQUENCING MARKET: BY PRODUCT & SERVICE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product & Service
• 4.2. Consumables (Extraction & Purification Kits, Library Preparation Kits, Sequencing Reagents & Flow Cells, Others) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Service (RNA-Sequencing, Bioinformatics & Data Analysis) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL NEXT GENERATION RNA SEQUENCING MARKET: BY WORKFLOW 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Workflow
• 5.2. Pre-Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Data Analysis Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL NEXT GENERATION RNA SEQUENCING MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Drug Discovery & Development (Oncology, Infectious Diseases, Others) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Clinical Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL NEXT GENERATION RNA SEQUENCING MARKET: BY END USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End Use
• 7.2. Academic & Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Pharmaceutical & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Hospitals & Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL NEXT GENERATION RNA SEQUENCING MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product & Service
  • 8.2.2 By Workflow
  • 8.2.3 By Application
  • 8.2.4 By End Use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product & Service
  • 8.3.2 By Workflow
  • 8.3.3 By Application
  • 8.3.4 By End Use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Spain
  • 8.3.10 Russia
  • 8.3.11 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product & Service
  • 8.4.2 By Workflow
  • 8.4.3 By Application
  • 8.4.4 By End Use
  • 8.4.5 China
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 India
  • 8.4.9 Australia
  • 8.4.10 South East Asia
  • 8.4.11 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product & Service
  • 8.5.2 By Workflow
  • 8.5.3 By Application
  • 8.5.4 By End Use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product & Service
  • 8.6.2 By Workflow
  • 8.6.3 By Application
  • 8.6.4 By End Use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL NEXT GENERATION RNA SEQUENCING INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Illumina Inc
  • 10.2.2 Thermo Fisher Scientific Inc
  • 10.2.3 Merck KGaA
  • 10.2.4 QIAGEN N.V
  • 10.2.5 Pacific Biosciences Of California Inc
  • 10.2.6 Oxford Nanopore Technologies Ltd
  • 10.2.7 Agilent Technologies Inc
  • 10.2.8 BGI Group
  • 10.2.9 Roche Holding AG
  • 10.2.10 Revvity Inc
  • 10.2.11 Eurofins Scientific
  • 10.2.12 Bio-Rad Laboratories Inc
  • 10.2.13 Takara Bio Inc
  • 10.2.14 Hamilton Company
  • 10.2.15 Macrogen